Glucagon-like-peptide-1 receptor agonists versus dipeptidyl peptidase-4 inhibitors and cardiovascular outcomes in diabetes in relation to achieved glycemic control. A Danish nationwide study
Zareini, B., Sørensen, K. K., Pedersen-Bjergaard, U., Loldrup Fosbøl, E., Køber, L. & Torp-Pedersen, C., jun. 2024, I: Journal of Diabetes. 16, 6, s. e13560
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review
